English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45018/58195 (77%)
造訪人次 : 2056456      線上人數 : 1653
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/5053


    題名: 大豆發酵乳對人體之腸胃菌叢及血脂之影響
    The Effects of Fermented Soymilk on Human Gut Microflora and Blood Lipids
    作者: 鄭佾琪
    I-Chi Cheng
    貢獻者: 保健營養學研究所
    關鍵詞: 大豆發酵乳
    腸胃菌叢
    血脂
    抗氧化
    Fermented soymilk
    Gut microflora
    Blood lipids
    Antioxidant
    日期: 2005
    上傳時間: 2009-09-10 18:02:50 (UTC+8)
    摘要: 本研究目的在於探討大豆發酵乳是否有益於人體腸道益生菌生長,及對血脂方面是否具正面功效。第一部份為腸道菌叢研究,篩選無腸胃道方面的疾病及其他健康問題者,年齡介於 21 至 26 歲,性別不拘,共 26 位,以交叉實驗及自體比較方式進行,為期八週,前兩週為排空期,接著兩週為實驗第一期,其後兩週為排空期,接著兩週為實驗第二期。受試者隨機分為兩組:YuSoy 組在第一期飲用大豆發酵乳,第二期飲用未發酵豆漿;而 SoyYu 組第一期飲用未發酵豆漿,第二期飲用大豆發酵乳 (每日攝取 500 mL 飲料)。收集糞便進行微生物活菌數檢測。結果發現飲用大豆發酵乳兩週後,受試者檢體中 Bifidobacterium spp. 及 Lactobacillus spp. 與總厭氧菌之比值,比飲用豆漿後顯著增加 (p < 0.05),Clostridium perfringens 比飲用豆漿後活菌數顯著下降 (p < 0.05)。第二部份為血脂研究,篩選血脂部分偏高之受試者,年齡介於 20 至 55 歲,性別不拘,共 18 位。實驗前兩週為穩定期,接著六週為實驗期,之後兩週為恢復期,實驗期間每天攝取大豆發酵乳 500 mL,於實驗期第零、二、四及六週取得空腹八小時血液進行生化分析,並於實驗期第零及及六週取得在飲用大豆乳酸飲料三小時後之血液進行血漿異黃酮素分析。結果發現,血清低密度脂蛋白膽固醇 (LDL-C) 顯著降低 (p < 0.05),三酸甘油酯濃度 (大於 160 mg/dL 之受試者) 顯著降低 (p < 0.05),高密度脂蛋白膽固醇濃度 (小於 40 mg/dL 之受試者) 顯著增加 (p < 0.05),而總膽固醇無顯著差異。在抗氧化指標方面,血漿總抗氧化力、紅血球中麩胱甘?濃度與超氧歧化?活性顯著增加 (p < 0.05),紅血球中觸?活性無差異性,而血漿脂質過氧化物濃度顯著減少 (p < 0.05),LDL 氧化延遲時間顯著延長 34 min (p < 0.05)。本篇證實飲用大豆發酵乳可增加腸道益生菌及降低有害菌之量,而飲用六週後則可促進體內抗氧化力並降低脂質過氧化物含量,對血脂濃度具有正面功效,因此大豆發酵乳對人體具有益處。
    The objective of this study was to investigate the effects of fermented soymilk on human gut microflora and blood lipids. In section one, a cross-over clinical and self-controlled study was performed, in which 26 subjects (21-26 years of age) were randomly divided into two groups. The subjects in the YuSoy group (n = 13) drank fermented soymilk in the first experimental period, while the subjects in the SoyYu group (n = 13) drank soymilk in the first experimental period. Each subject consumed 500 mL of soy drink a day. After two weeks, in the period of fermented soymilk-drinking, the ratios of Bifidobacterium spp. to total anerobic organisms and Lactobacillus spp. to total anerobic organisms significantly increased when compared to those in the soymilk-drinking period (p < 0.05). The population of Clostridium perfringens significantly decreased when compared to those in the soymilk-drinking period (p < 0.05). In section two, a 6-wk clinical and self-controlled study was performed, in which 18 subjects (20-55 years of age) consumed 500 mL of fermented soymilk a day. Blood samples were collected. Blood lipids and antioxidative indexes were measured. After fermented soymilk consumption, the concentration of LDL-cholesterol significantly decreased (p < 0.05), and the concentration of triglycerides in those whose > 160 mg/dL significantly decreased (p < 0.05), and the concentration of HDL-cholesterol in those whose < 40 mg/dL significantly increased (p < 0.05). There was no difference in cholesterol. On the other hand, the concentration of plasma total antioxidant status and glutathione of RBC significantly increased (p < 0.05), while the superoxide dismutase activity significantly increased (p < 0.05). There was no difference in catalase activity of RBC. The thiobarbuturic acid reactive substrance (TBARs) significantly decreased, and the LDL-lag time significantly increased (p < 0.05). These findings indicated that fermented soymilk consumption significantly improved probiotic counts in the human gastrointestinal tract in a two-week period, while the antioxidative condition was improved in a six-week period.
    資料類型: thesis
    顯示於類別:[保健營養學系暨研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc29KbMicrosoft Word129檢視/開啟
    摘要.pdf70KbAdobe PDF165檢視/開啟
    摘要.ppt124KbMicrosoft Powerpoint177檢視/開啟
    摘要.ps402KbPostscript64檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋